Gene Query: AGRN

Dataset Description Geneva Score
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 99.37
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia [RNA-seq] 96.49
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia 96.49
The effect of PPARG inhibition on human angiomyolipoma cells 57.9
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 56.72
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 53.32
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 52.37
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 48.01
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 47.3
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 46.87
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 45.56
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 45.45
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 44.84
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 44.84
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 44.84
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 43.95
Gene expression profiling of KSHV-infected periodontal ligament cells 43.72
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 43.53
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 42.45
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 41.36
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 41.16
hnRNP C is a key regulator of protein synthesis in mitosis 39.64
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 39.64
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 39.63
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 39.58
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 39.43
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 37.96
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 36.84
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 36.84
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 36.57
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 35.99
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 35.48
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 34.75
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 34.6
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 33.89
MOF acetyl transferase regulates transcription and respiration in mitochondria 33.72
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 33.58
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 33.24
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 32.47
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 32.44
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 32.05
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 31.62
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 31.58
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 30.91
Molecular Mechanisms of Endothelial Hyperpermeability 30.88
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 30.69
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 30.56
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 30.36
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 30.05
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 29.99
circRNA-sequencing 29.86
Genome wide expression change by RNF168 knocking down in NEC cells 29.52
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 28.72
Generation and functional characterization of MDSC-like cells 28.63
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 28.58
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 28.36
Effect of BB608 on Gene Expression in HNSCC Cell Line 28.3
An RNA-centric dissection of host complexes controlling flavivirus infection 28.14
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 28.14
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 27.97
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 27.9
RNA-seq analysis of AML cells in response to ASLAN003 27.79
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 27.76
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 27.65
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 27.3
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 27.07
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 27.07
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 26.93
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 26.92
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 26.92
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 26.85
Role of XRN2 ribonucleolytic activity in RNA metabolism 26.78
Modeling Familial Cancer with iPSC Approaches 26.43
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 26.3
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 26.1
Landscape of H3K4me3 in human CD19 cells 25.99
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 25.96
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 25.29
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 25.21
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 24.78
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 24.71
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 24.62
Effects of rFVIIIFc on human macrophages 24.6
CD86 regulates a pro-survival signal in myeloma cells 24.57
DART-seq: an antibody-free method for global m6A detection 24.56
Transcriptome analysis upon C6orf203 silencing 24.4
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 24.25
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 24.22
Pharmacologic inhibition of STAT5 in AML 23.76
Genetic-to-epigenetic Therapy for Pancreatic Cancer 23.62
circRNA profile in hypopharyngeal cancer 23.57
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 23.51
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 23.47
Recovery and analysis of nascent RNA 23.21
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 23.21
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 23.09
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 22.94
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 22.94
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 22.53
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 22.03
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 21.88
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 21.86
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 21.82
Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration 21.7
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 21.64
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 21.62
RNA Sequencing of three pairs of gastric cancer 21.56
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 21.46
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 21.43
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 21.43
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 21.42
Gene expression changes upon drug withdrawal (Mel888 cell line) 21.33
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 21.27
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 20.84
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 20.62
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 20.62
Gene expression changes associated with resistance to tagraxofusp (SL-401) 20.39
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 20.36
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 20.26
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 19.92
RNA-seq of cancer cell lines treated with T-025 19.92
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 19.63
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 19.63
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 19.54
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 19.51
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 19.46
Accurate annotation of human protein-coding small open reading frames 19.46
TGF-β regulation of miRNA expression in pancreatic cancer 19.42
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 19.39
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 19.28
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 19.27
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 19.24
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 19.2
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 19.03
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 18.93
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 18.93
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 18.82
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 18.82
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 18.81
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 18.81
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 18.8
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 18.79
Global gene expression profile of dasatinib-resistant RCH-ACV cells 18.67
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 18.55
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 18.41
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 18.41
Expression profiling of etoposide-induced senescent cells 18.26
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 18.15
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 18.15
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 18.11
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 17.89
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 17.89
Transcriptomes of human monocytes after ex vivo exposure to uric acid 17.76
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 17.75
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 17.75
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 17.71
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 17.71
Gene expression analysis of the impact of TDP-43 knockout in human cells. 17.63
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 17.59
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 17.58
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 17.57
Hepatitis C virus functionally sequesters miR-122 17.34
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 17.34
FBXW7 modulates stress response by post-translational modification of HSF1 17.3
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 17.3
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 17.29
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 17.21
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 17.18
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 17.15
RNA sequencing with KSHV infection and enrichment for circular RNAs 17.09
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 17.03
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 17.01
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 16.91
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 16.91
Transcriptome analysis of kidney organoids 16.88
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 16.82
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 16.77
Non-coding regions are the main source of tumor-specific antigens [human] 16.74
Non-coding regions are the main source of tumor-specific antigens 16.74
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 16.68
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 16.68
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 16.68
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 16.58
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 16.53
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 16.5
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 16.47
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 16.45
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 16.45
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 16.41
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 16.09
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 16.03
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 15.99
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 15.96
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 15.89
circRNA-sequencing 15.82
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 15.8
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 15.78
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 15.78
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 15.65
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 15.64
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 15.64
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 15.63
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 15.63
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 15.59
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 15.52
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 15.44
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 15.44
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 15.43
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 15.4
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 15.4
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 15.4
Mechanistic Model-Guided Study of Embryonic Morphogenesis 15.28
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 15.23
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 15.2
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 15.09
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 15.01
Argonaute proteins couple chromatin silencing to alternative splicing 15.0
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 15.0
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 14.99
LNCaP treated with iBET 14.98
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 14.98
RNA-sequencing of human peripheral blood mononuclear cells (PB MNCs) and induced neural progenitor cells derived from PB MNCs 14.93
RNA-seq of MDA-MB-231 cells with TET1 knockout 14.88
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 14.86
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 14.83
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 14.83
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 14.8
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 14.78
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 14.7
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 14.7
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 14.58
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 14.55
Epigenomic landscape during organ formation in human early embryos 14.51
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 14.48
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 14.42
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 14.39
Polarized B -cell functions 14.39
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 14.37
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 14.34
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 14.26
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 14.19
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 14.12
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 14.12
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 14.06
Identification of the role of polydom in neurofibromas 13.95
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 13.81
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 13.75
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 13.67
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 13.41
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 13.17
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 13.08
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 13.06
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 12.94
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 12.92
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 12.92
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 12.85
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 12.83
Transcriptome of Stabilin-1 siRNA transfected human monocytes 12.76
Transcriptome profiling of Normal and Cancerous Prostate Cells 12.72
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 12.72
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 12.68
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 12.68
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 12.66
mRNA recovered upon RNF219 IP. [RNA-IP] 12.64
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 12.56
Effect of from Human Umbilical Vein Endothelial Cells 12.55
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 12.52
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 12.5
An siRNA screen identifies CHD4 as a target for epigenetic therapy 12.47
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 12.46
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 12.46
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 12.43
LncRNA-GAS5 negative regulation of YAP-target genes expression 12.42
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 12.38
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 12.38
Postnatal lipids drive hepatocyte maturation 12.34
High-throughput sequencing of pluripotent cells 12.33
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 12.3
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 12.15
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 12.15
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 12.13
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 12.03
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 11.97
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 11.94
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 11.78
Regulation of poly(A) tail and translation during the somatic cell cycle 11.69
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 11.6
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 11.6
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 11.52
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 11.47
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 11.42
TT-Seq captures the human transient transcriptome 11.41
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 11.37
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 11.37
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 11.37
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 11.37
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 11.35
Toxoplasma gondii infection of human retinal pigment epithelial cells 11.31
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 11.29
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 11.09
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 11.05
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 11.05
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 11.03
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 10.83
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 10.82
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 10.74
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 10.72
RNA Seq of HMVEC under hypoxia 10.72
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 10.69
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 10.65
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 10.62
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 10.4
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 10.32
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 10.17
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 10.14
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 10.14
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 10.08
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 10.07
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 10.07
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 9.75
A novel target of EZH1/2 for treatment of mantle cell lymphoma 9.7
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 9.68
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 9.59
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 9.48
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 9.36
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 9.35
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 9.26
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 9.25
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 9.25
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 9.16
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 9.16
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 9.11
Lung Cancer Cell-Mediated Skeletal Muscle Mitochondrial Dysfunction is Mitigated by 1a,25-Dihydroxyvitamin D3 8.93
Analysis by Whole Transcriptome Sequencing of the Effects of LLC1 conditioned medium, LLC1 conditioned plus Calcitriol, non-conditioned medium, and non-conditioned medium plus Calcitriol on mRNA Expression in Primary Human Skeletal Muscle Cells 8.93
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 8.86
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 8.86
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 8.79
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 8.45
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 8.42
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 8.4
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 8.3
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 8.28
Comparative Analysis of Cas9 Activators Across Multiple Species 8.21
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 8.05
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 8.05
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 7.87
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 7.87
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 7.87
Androgen Receptor-regulated genes in prostate cancer cells 7.67
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 7.67
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 7.53
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 7.32
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 7.32
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 7.32
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 7.27
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 7.22
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 7.19
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 7.19
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 7.11
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 7.01
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 6.98
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 6.9
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 6.89
RNA-seq differential expression studies: more sequence, or more replication? 6.83
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 6.68
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 6.39
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 6.35
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 6.34
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 6.3
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 6.3
KSDM1b Role in Ewing Sarcoma 6.27
Identification of long noncoding RNAs in T-ALL cell lines 6.2
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 6.19
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 6.04
Ribosomal protein RPL26 is the principal target of UFMylation 6.02
Impact on erythroid progenitor type on erythroid differntiation 5.98
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 5.97
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 5.96
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 5.96
RNA-seq of SCLC PDX models treated with EP 5.89
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 5.8
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 5.74
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 5.69
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 5.69
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 5.69
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 5.69
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 5.68
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 5.68
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 5.6
A practical evaluation of alignment algorithms for RNA variant calling analysis 5.59
Identification of differentially expressed genes between senescence and senescence bypass cells 5.4
Transcriptome Profiling of Human Primary Monocytes 5.39
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 5.38
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 5.35
Trascriptome of thyroid cancer-induced macrophages 5.24
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 5.22
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 5.12
6mer seed toxicity in tumour suppressive microRNAs 5.01
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 5.0
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 5.0
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 4.92
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 4.88
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 4.87
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 4.78
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 4.76
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 4.75
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 4.74
Primate transcript and protein expression levels evolve under compensatory selection pressures 4.61
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 4.57
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 4.54
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 4.53
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 4.36
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 4.34
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 4.34
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 4.33
Studying the selectivity of a small molecule Synucleozid on transcriptome 4.31
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 4.27
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 4.27
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 4.26
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 4.22
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 3.96
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 3.96
Human islets of varying quality: the good, the (not so) bad and the ugly 3.96
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 3.94
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 3.87
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 3.87
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 3.85
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 3.84
SRSF1 role in cellular gene expression and splicing 3.81
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 3.74
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 3.61
RNA-seq of cells with TET1 knockout 3.44
DAOY-Notch1/Notch2 knockout: transcriptome comparison 3.37
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 3.36
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 3.33
Transcriptome analyses of human pancreatic islets and pseudoislets 3.08
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 3.08
The pioneer factor CEBPA modulates vitamin D signaling 3.08
Ribosome profiling upon inhibition of eIF4A 2.98
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 2.94
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 2.94
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 2.7
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 2.66
Gene expression profile of regenerated CD8αα T cells and CD8αβ T cells from LMP2 T-iPSCs 2.66
MicroRNA Marker Based Prognostication of Oral Squamous Cell Carcinoma 2.58
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 2.47
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 2.47
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 2.46
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 2.38
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 2.34
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 2.16
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 2.1
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 2.03
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 2.02
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 2.01
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 1.97
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 1.95
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 1.89
Leucegene: AML sequencing (part 6) 1.85
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 1.79
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 1.78
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 1.78
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 1.75
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.72
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 1.71
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 1.59
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 1.57
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 1.56
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 1.52
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 1.4
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 1.31
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 1.14
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 1.14
The DPYSL2 gene connects mTOR and schizophrenia 1.12
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.91
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 0.88
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 0.8
Transcriptome analysis reveals differential splicing events in IPF lung tissue 0.77
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 0.76
RNA expression profiles comparing primary and omental ovarian carcinoma samples 0.74
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 0.67
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 0.67
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 0.67
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 0.65
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.58
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.56
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 0.49
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.43
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 0.38
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 0.35
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.32
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 0.26
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 0.23
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.23
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 0.23
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 0.21
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 0.11
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 0.11
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 0.1
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 0.1


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation